Immunotherapy for Esophageal Cancer: State-of-the Art in 2021

SIMPLE SUMMARY: The aim of this review was to describe the rationale for immunotherapy in different stages of esophageal cancer (EC) treatment, with a particular accent on curative intent treatment of locally advanced disease for the two predominant histological types (adenocarcinoma and squamous ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Teixeira Farinha, Hugo, Digklia, Antonia, Schizas, Dimitrios, Demartines, Nicolas, Schäfer, Markus, Mantziari, Styliani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833794/
https://www.ncbi.nlm.nih.gov/pubmed/35158822
http://dx.doi.org/10.3390/cancers14030554

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833794/
https://www.ncbi.nlm.nih.gov/pubmed/35158822
http://dx.doi.org/10.3390/cancers14030554

Ejemplares similares